BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11570524)

  • 1. T-cell-mediated mucosal immunity in the absence of antibody: lessons from Helicobacter pylori infection.
    Ernst PB; Pappo J
    Acta Odontol Scand; 2001 Aug; 59(4):216-21. PubMed ID: 11570524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive and therapeutic vaccines against Helicobacter pylori: current status and future challenges.
    Ernst PB; Pappo J
    Curr Pharm Des; 2000 Oct; 6(15):1557-73. PubMed ID: 10974152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host response and vaccine development to Helicobacter pylori infection.
    Blanchard TG; Czinn SJ; Nedrud JG
    Curr Top Microbiol Immunol; 1999; 241():181-213. PubMed ID: 10087662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori infection as a model for gastrointestinal immunity and chronic inflammatory diseases.
    Ernst PB; Takaishi H; Crowe SE
    Dig Dis; 2001; 19(2):104-11. PubMed ID: 11549818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced T-helper 2 lymphocyte responses: immune mechanism of Helicobacter pylori infection.
    Fan XG; Yakoob J; Fan XJ; Keeling PW
    Ir J Med Sci; 1996; 165(1):37-9. PubMed ID: 8867497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori and T Helper Cells: Mechanisms of Immune Escape and Tolerance.
    Larussa T; Leone I; Suraci E; Imeneo M; Luzza F
    J Immunol Res; 2015; 2015():981328. PubMed ID: 26525279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immune response against Helicobacter pylori--a direct linkage to the development of gastroduodenal disease.
    Ibraghimov A; Pappo J
    Microbes Infect; 2000 Jul; 2(9):1073-7. PubMed ID: 10967287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal immune responses are related to reduction of bacterial colonization in the stomach after therapeutic Helicobacter pylori immunization in mice.
    Nyström J; Raghavan S; Svennerholm AM
    Microbes Infect; 2006 Feb; 8(2):442-9. PubMed ID: 16243563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of type-specific antibodies in colonization and infection by Helicobacter pylori.
    Akhiani AA
    Curr Opin Infect Dis; 2005 Jun; 18(3):223-7. PubMed ID: 15864099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation, immunity and vaccines for Helicobacter pylori.
    Del Giudice G; Michetti P
    Helicobacter; 2004; 9 Suppl 1():23-8. PubMed ID: 15347302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of H. pylori infected mice with antioxidant astaxanthin reduces gastric inflammation, bacterial load and modulates cytokine release by splenocytes.
    Bennedsen M; Wang X; Willén R; Wadström T; Andersen LP
    Immunol Lett; 1999 Dec; 70(3):185-9. PubMed ID: 10656672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell subsets play an important role in the determination of the clinical outcome of Helicobacter pylori infection.
    Jafarzadeh A; Larussa T; Nemati M; Jalapour S
    Microb Pathog; 2018 Mar; 116():227-236. PubMed ID: 29407232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host Nonresponsiveness Does not Interfere With Vaccine-Mediated Protection Against Gastric Helicobacter Infection.
    Harbour SN; Mitchell HM; Sutton P
    Helicobacter; 2015 Jun; 20(3):217-22. PubMed ID: 25683672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-independent protective mucosal immunity to gastric helicobacter infection in mice.
    Blanchard TG; Czinn SJ; Redline RW; Sigmund N; Harriman G; Nedrud JG
    Cell Immunol; 1999 Jan; 191(1):74-80. PubMed ID: 9918689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori inflammation, immunity, and vaccines.
    D'Elios MM; Andersen LP
    Helicobacter; 2007 Oct; 12 Suppl 1():15-9. PubMed ID: 17727455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulation of helicobacter infection.
    Croitoru K
    Can J Gastroenterol; 1999 Apr; 13(3):237-41. PubMed ID: 10331935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccines.
    Lee A
    Eur J Gastroenterol Hepatol; 1999 Aug; 11 Suppl 2():S75-9. PubMed ID: 10503828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HELICOBACTER PYLORI INFECTION AND IMMUNE PROFILE OF PATIENTS WITH DIFFERENT GASTRODUODENAL DISEASES.
    Vinagre RMDF; Vinagre IDF; Vilar-E-Silva A; Fecury AA; Martins LC
    Arq Gastroenterol; 2018; 55(2):122-127. PubMed ID: 30043859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of T helper 1-cell response in Helicobacter pylori-infection.
    Bagheri N; Salimzadeh L; Shirzad H
    Microb Pathog; 2018 Oct; 123():1-8. PubMed ID: 29936093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori stimulates a mixed adaptive immune response with a strong T-regulatory component in human gastric mucosa.
    Goll R; Gruber F; Olsen T; Cui G; Raschpichler G; Buset M; Asfeldt AM; Husebekk A; Florholmen J
    Helicobacter; 2007 Jun; 12(3):185-92. PubMed ID: 17492997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.